Skip to main content
. 2021 Mar 9;151(5):1128–1138. doi: 10.1093/jn/nxaa435

TABLE 3.

Plasma NMR-derived lipid particle concentrations and size in pregnant women with obesity at risk of gestational diabetes that were or were not supplemented with blueberries and soluble fiber for 18 wk of pregnancy1

Variable by group Baseline2 Midpoint3 End4 P value5 (group) P value5 (time) P value5 (interaction)
Plasma total VLDL and chylomicron particles, nmol/L 0.04 0.09 0.25
 Intervention 39.2 ± 22.5 44.2 ± 20.4 54.4 ± 43.4
 Control 52.2 ± 18.4 52.9 ± 19.9 55.0 ± 23.3
Plasma large VLDL and chylomicron particles, nmol/L 0.78 0.62 0.68
 Intervention 4.7 ± 4.4 3.8 ± 3.0 4.5 ± 3.5
 Control 4.2 ± 1.8 4.3 ± 2.5 4.7 ± 2.7
Plasma medium VLDL particles, nmol/L 0.31 0.34 0.62
 Intervention 16.0 ± 11.7 16.3 ± 11.7 21.1 ± 16.0
 Control 21.7 ± 12.4 18.7 ± 9.5 24.5 ± 16.6
Plasma small VLDL particles, nmol/L 0.02 0.78 0.15
 Intervention 20.2 ± 11.1 25.5 ± 14.8 24.1 ± 17.0
 Control 29.6 ± 12.5 27.7 ± 12.4 25.8 ± 12.6
Plasma total LDL particles, nmol/L 0.69 0.004 0.48
 Intervention 1220 ± 325 1300 ± 361 1390 ± 386
 Control 1120 ± 323 1150 ± 326 1260 ± 345
Plasma IDL particles, nmol/L 0.38 0.07 0.78
 Intervention 173 ± 132 194 ± 145 217 ± 147
 Control 124 ± 62 147 ± 104 157 ± 97
Plasma large LDL particles, nmol/L 0.14 0.49 0.75
 Intervention 673 ± 396 736 ± 247 710 ± 308
 Control 408 ± 283 473 ± 358 527 ± 405
Plasma total small LDL particles, nmol/L 0.03 0.07 0.56
 Intervention 348 ± 452 417 ± 476 517 ± 496
 Control 722 ± 390 690 ± 463 826 ± 463
Plasma total HDL particles, μmol/L 0.48 0.03 0.41
 Intervention 34.5 ± 7.0 33.5 ± 7.2 31.8 ± 8.1
 Control 33.5 ± 6.7 32.7 ± 7.7 32.2 ± 5.8
Plasma large HDL particles, μmol/L 0.83 0.60 0.76
 Intervention 13.2 ± 4.3 14.5 ± 3.3 14.2 ± 3.7
 Control 13.5 ± 3.9 13.1 ± 3.4 12.9 ± 3.3
Plasma medium HDL particles, μmol/L 0.62 0.21 0.22
 Intervention 4.9 ± 5.4 4.5 ± 3.8 5.3 ± 3.2
 Control 5.5 ± 5.9 5.5 ± 6.2 2.9 ± 1.9
Plasma small HDL particles, μmol/L 0.76 0.44 0.32
 Intervention 16.1 ± 5.5 15.7 ± 6.1 14.5 ± 5.3
 Control 16.0 ± 5.7 14.3 ± 5.1 16.2 ± 4.5
Plasma VLDL size, nm 0.48 0.83 0.73
 Intervention 53.0 ± 6.2 53.4 ± 6.3 53.0 ± 6.8
 Control 51.6 ± 4.3 52.7 ± 5.6 52.3 ± 5.8
Plasma LDL size, nm 0.07 0.18 0.46
 Intervention 20.0 ± 1.5 20.8 ± 0.5 20.8 ± 0.8
 Control 20.3 ± 1.3 20.4 ± 0.5 20.5 ± 0.6
Plasma HDL size, nm 0.98 0.26 0.73
 Intervention 10.0 ± 0.6 10.2 ± 0.4 10.2 ± 0.3
 Control 10.5 ± 1.5 10.0 ± 0.3 10.0 ± 0.3
1

n = 17 for each group. Values are mean ± SD unless otherwise indicated. Intervention: blueberry + soluble fiber; control: standard prenatal care.

2

Gestational week 16.0 ± 3.8 for intervention and 14.5 ± 4.4 for control.

3

Gestational week 26.5 ± 1.3 for intervention and 26.0 ± 1.2 for control.

4

Gestational week 34.0 ± 1.3 for intervention and 33.0 ± 2.3 for control.

5

P from mixed-model ANOVA.